Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06977438 · ClinicalTrials.gov registry record · Phase 4
GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward
A Phase 4 study, sponsored by University of Minnesota.
- Not yet
- Registry status
- Phase 4
- Development phase
- 1,020
- Enrollment target
NCT06977438: Clinical Trial Phase 4 study, sponsored by University of Minnesota.
NCT06977438 is a Phase 4 study that has not yet begun recruiting, run by University of Minnesota. The registered enrollment target is 1,020 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06977438, a Phase 4 study, has not yet begun recruiting, sponsored by University of Minnesota.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 1,020 participants
- Enrollment target
Study Summary
The rapid emergence of new and highly effective obesity medications has turned the field of pediatric weight management on its head. Adolescents living with obesity, their caregivers, healthcare providers, healthcare systems, policymakers, and payors are now wondering what role health behavior and lifestyle treatment (HBLT) has in terms of body mass index (BMI) reduction, improvements in quality of life and cardiometabolic health, and mitigating nutritional concerns when medications are used. Is intensive HBLT needed or could low intensity HBLT be an equally effective alternative; and if so, for whom? Our proposed project will answer these important questions that arise daily in the clinical setting and will generate critical new insights to guide decision-making for teens with obesity and the stakeholders who care deeply about them.
Primary Outcome
Change in body mass index
Interventions
- DRUG Semaglutide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,020 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2032-01-31 |
| Phase | Phase 4 |
What is known before NCT06977438 opens enrollment
NCT06977438 is an interventional study that assigns participants to a tested intervention. Its 1,020 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% higher).
The record links to 0 conditions, and to 1 intervention - of which Semaglutide is the first listed.
NCT06977438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06977438 about?
NCT06977438 is a clinical study titled "GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward". The rapid emergence of new and highly effective obesity medications has turned the field of pediatric weight management on its head. Adolescents living with obesity, their caregivers, healthcare providers, healthcare systems, policymakers, and payors are now wondering what role health behavior and l...
What is the current status of trial NCT06977438?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 1,020 participants. The study started on 2026-10-01. Estimated completion is 2032-01-31.
What interventions are being tested in trial NCT06977438?
The interventions under investigation include: Semaglutide (DRUG).
Who is sponsoring clinical trial NCT06977438?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06977438's enrollment target sits among peer trials
1,020 66th of 2000 higher than 1,935 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02178163 · 1,020 participants · NA
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
- NCT05225428 · 1,020 participants · NA
Video Education With Result Dependent dIsclosure
- NCT06697600 · 1,020 participants · NA
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
- NCT06760637 · 1,020 participants · Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI